We use cookies to ensure our website works properly and to personalise your experience. Cookies policy
Department Of Pharmaceutical Quality Assurance, Rajaram Bapu College Of Pharmacy, Kasegaon, Maharashtra, India 415404.
Bilayer tablet technology has emerged as an advanced oral drug delivery strategy for achieving controlled, sustained, and combination drug release within a single dosage unit. The system allows incorporation of two incompatible drugs, separation of release profiles, and improvement in therapeutic efficacy and patient compliance. This review presents a comprehensive overview of bilayer tablets with emphasis on formulation strategies, excipient selection, manufacturing techniques, drug release mechanisms, evaluation methods, and therapeutic applications. The paper also discusses challenges associated with interlayer adhesion, compression parameters, scale-up, and regulatory aspects. Furthermore, the role of Quality by Design (QbD), Process Analytical Technology (PAT), and emerging industrial trends in enhancing bilayer tablet performance is critically analyzed. The review highlights recent advances and prospects in the development of bilayer tablets as a versatile platform for controlled release and fixed-dose combination therapies.
Oral drug delivery remains the most preferred route of administration due to its convenience, patient compliance, and cost-effectiveness. However, conventional dosage forms often fail to provide optimal therapeutic outcomes due to fluctuations in drug plasma concentration, frequent dosing requirements, and incompatibility between multiple active pharmaceutical ingredients. Bilayer tablet technology has emerged as a promising approach to overcome these limitations by integrating two drug layers or release profiles into a single dosage unit [1]. Bilayer tablets are designed to deliver drugs either simultaneously or sequentially through immediate-release and sustained-release mechanisms. This technology is particularly useful for combination therapy, chronotherapeutic delivery, and management of chronic diseases where multidrug therapy is required [2], [3]. The development of bilayer tablets has gained significant attention due to their ability to enhance therapeutic efficacy, improve patient adherence, and reduce dosing frequency. Nevertheless, the formulation and manufacturing of bilayer tablets involve complex challenges such as layer separation, compression optimization, and drug compatibility issues [4]. Recent research has focused on improving formulation strategies, evaluating excipient interactions, and addressing manufacturing challenges associated with bilayer tablet production [5], [6]. Academic and industrial investigations have also highlighted the importance of equipment design, process control, and polymer selection in achieving desired drug release profiles [7], [8]. Numerous case studies and formulation reports have demonstrated the application of bilayer tablets in various therapeutic areas, including cardiovascular disorders, diabetes, and gastrointestinal diseases [9], [10]. Additionally, industrial and academic repositories have provided valuable insights into manufacturing processes and equipment considerations for bilayer tablet development [11], [12].
Fundamentals of Bilayer Tablet Technology
Bilayer tablets consist of two distinct layers compressed into a single unit, each designed to perform a specific function such as immediate drug release, sustained release, or separation of incompatible active pharmaceutical ingredients. The concept is based on modifying drug release kinetics while maintaining mechanical integrity of the tablet [13]. The primary objective of bilayer technology is to achieve differential release patterns that can optimize therapeutic outcomes and reduce adverse effects. This can be achieved through appropriate selection of polymers, excipients, and compression techniques [14]. Bilayer systems are broadly categorized into sustained-release/immediate-release combinations, floating bilayer systems, and combination drug therapies. Each system is designed to meet specific pharmacokinetic and therapeutic requirements [15]. Industrial development of bilayer tablets involves careful consideration of powder flow, compressibility, and adhesion between layers. The success of bilayer technology largely depends on optimization of formulation variables and manufacturing parameters [16]. Recent academic contributions and methodological studies have provided detailed insights into formulation approaches and process development strategies for bilayer tablets [17], [18].
Figure 1: Conceptual drug release profile of bilayer tablet showing immediate and sustained drug release
Advantages and Disadvantages of Bilayer Tablets
Bilayer tablet technology offers several therapeutic and formulation advantages; however, certain technical and manufacturing limitations are also associated with this system. The major advantages and disadvantages reported in the literature are discussed below.
Advantages of Bilayer Tablets
Disadvantages of Bilayer Tablets
Formulation Strategies and Excipients
Formulation design plays a critical role in determining the performance of bilayer tablets. Selection of suitable excipients ensures mechanical strength, drug stability, and controlled drug release. Polymers, binders, diluents, and disintegrants are carefully chosen to achieve desired functional properties [19]. Common polymers used include hydrophilic matrix formers such as HPMC, carbopol, and polyethylene oxide, which regulate drug release through swelling and diffusion mechanisms. Hydrophobic polymers may also be incorporated to modify release kinetics [20]. Floating bilayer tablets and gastro-retentive systems require specific excipients such as gas-generating agents and low-density polymers to maintain buoyancy and prolong gastric residence time [21]. Academic and industrial studies emphasize the importance of excipient compatibility and optimization of polymer ratios to ensure stability and performance of bilayer systems [22].
Regional journal publications and formulation studies have demonstrated diverse excipient combinations tailored to therapeutic requirements and manufacturing feasibility [23], [24].
Figure 2: Structure of bilayer tablet showing immediate and sustained release layers
Manufacturing Techniques & Equipment
Manufacturing of bilayer tablets requires specialized compression techniques capable of producing two distinct layers with adequate bonding. The process typically involves sequential filling and compression within a single die cavity [25]. Industrial equipment such as rotary bilayer tablet presses enables precise control of weight, compression force, and layer thickness. Advances in feeder design and automation have significantly improved manufacturing reproducibility [26]. Granulation techniques including wet granulation, dry granulation, and direct compression are commonly employed depending on drug and excipient properties [27]. Process optimization focuses on parameters such as compression force, dwell time, and powder flow to prevent delamination and ensure mechanical integrity [28]. Industrial reviews have highlighted scale-up challenges and process optimization strategies for large-scale bilayer tablet production [29].
Equipment innovations and automation technologies continue to enhance manufacturing efficiency and quality control [30]. In addition, pre-compression of the first layer is a critical step to provide sufficient mechanical strength while maintaining surface roughness for effective bonding with the second layer. Improper pre-compression can lead to poor interfacial adhesion and layer separation during handling and packaging [25]. Die filling accuracy and uniform powder distribution are essential to maintain consistent layer weight and content uniformity. Modern tablet presses are equipped with force feeders and automated weight control systems to ensure reproducibility in high-speed manufacturing environments [26]. Control of environmental conditions such as humidity and temperature is also important, as moisture-sensitive formulations may affect compressibility and interlayer adhesion during production [27]. Advanced instrumentation allows monitoring of compression profiles, ejection forces, and dwell time, which helps in identifying process deviations and maintaining tablet integrity during large-scale production [28]. Continuous manufacturing approaches and integrated control systems are increasingly being adopted to improve efficiency, reduce production time, and maintain consistent product quality in industrial bilayer tablet manufacturing [29], [30].
Figure 3: Bilayer tablet compression machine with dual hopper system
Drug Release Mechanisms and Kinetic Models
Immediate-release layers enable rapid onset of action, whereas sustained-release layers provide prolonged therapeutic effects through controlled drug diffusion [32]. Mathematical models such as zero-order, first-order, Higuchi, and Korsmeyer–Peppas are widely used to describe release kinetics and optimize formulation parameters [33]. Polymer characteristics and matrix composition significantly influence drug release behavior and stability [34]. Interlayer interactions and mechanical properties also affect release performance and must be considered during formulation development [35].
Evaluation and Characterization Methods
Pre-compression evaluation includes assessment of flow properties, compressibility, and powder density. These parameters influence uniformity and manufacturability of bilayer tablets [36]. Post-compression tests such as hardness, friability, thickness, and weight variation ensure structural integrity and dosage accuracy [37]. Advanced analytical techniques and experimental studies provide insights into interfacial strength, compression behavior, and mechanical performance of bilayer tablets [38]. Stability studies and analytical evaluations are essential for understanding degradation, drug release variation, and long-term performance [39]. Additional studies emphasize the importance of systematic characterization and optimization during bilayer tablet development [40].
Applications in Controlled Release & Fixed-Dose Combinations
Bilayer tablets are widely used in chronic disease management and fixed-dose combinations due to their ability to provide dual release profiles and improve patient compliance. These systems are particularly beneficial in cardiovascular, antidiabetic, and gastrointestinal therapies [41].
Clinical and industrial analyses highlight their effectiveness in delivering multidrug therapies with improved therapeutic outcomes [42]. Granulation and formulation approaches influence performance in combination therapy applications [43]. Controlled release and direct compression techniques have enabled development of patient-centric bilayer formulations [44]. Coating and protection strategies further enhance stability and drug release control in bilayer systems [45].
Advanced mechanical studies demonstrate improved adhesion and performance of optimized bilayer tablet designs [46].
Challenges in Bilayer Tablet Development
Bilayer tablet production faces challenges related to density variation, compression optimization, and mechanical stability [47]. Moisture sensitivity and bonding strength reduction may lead to delamination and product failure [48]. Quantitative measurement of interfacial strength is critical to ensure long-term stability and performance [49]. Complex release behavior and polymer interactions require advanced modeling and optimization [50]. In vitro–in vivo correlation studies are necessary to predict clinical performance [51]. Pharmacokinetic modeling supports formulation optimization and regulatory acceptance [52].
Quality by Design (QbD), PAT & Regulatory Considerations
Modern pharmaceutical development emphasizes systematic design and process understanding. QbD approaches identify critical quality attributes and process parameters for bilayer tablets [53].
Improved adherence and dosing strategies influence therapeutic success of controlled release systems [54]. Medication compliance studies support the importance of sustained and combination therapies [55]. Dose regimen optimization contributes to improved patient outcomes [56]. Integration of advanced delivery systems enhances sustained release performance [57].
Regulatory agencies encourage QbD-based development and risk assessment to ensure product quality and reproducibility [58].
Recent Advances and Industrial Trends
Green manufacturing and sustainable pharmaceutical processes are gaining importance in bilayer tablet production [59].Advances in polymer science and swellable matrix systems have improved drug release control and formulation flexibility [60].Film formation and coating technologies enhance stability and protection of bilayer systems [61].Industrial innovations and modern dosage form development continue to expand the application of bilayer tablets in pharmaceutical research and commercialization [62].
CONCLUSION
Bilayer tablet technology represents a significant advancement in oral controlled drug delivery systems. The ability to integrate immediate and sustained release profiles within a single dosage form provides therapeutic advantages and enhances patient compliance.
Formulation design, excipient selection, manufacturing optimization, and evaluation techniques are critical to achieving reliable bilayer tablet performance. Despite challenges related to interlayer adhesion, compression parameters, and scale-up, advancements in QbD, PAT, and industrial technologies have improved the feasibility of bilayer tablet development.
Future research should focus on polymer innovation, predictive modeling, and patient-centric drug delivery approaches. With continuous technological progress, bilayer tablets are expected to play a vital role in the development of advanced controlled release and fixed-dose combination therapies.
REFERENCES
review PDF). (ResearchGate)
(Jadhav, 2025). (WJPS Online)
International Journal of Pharmaceutical Research & Applications — review PDFs on bilayer dual-release systems (2023–2024). (JDDT)
review PDF). (ResearchGate)
(Jadhav, 2025). (WJPS Online)
International Journal of Pharmaceutical Research & Applications — review PDFs on bilayer dual-release systems (2023–2024). (JDDT)
Jyoti Awhad, Hemant Kandle, Rohan Mali, A Comprehensive Review on Bilayer Tablets for Controlled Release Systems: Development, Issues and Future Prospects, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 5, 1458-1466, https://doi.org/10.5281/zenodo.20068527
10.5281/zenodo.20068527